These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 23042369)

  • 1. Individualizing hormone-therapy according to cardiovascular risk.
    Shoupe D
    Minerva Med; 2012 Oct; 103(5):343-52. PubMed ID: 23042369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are oestrogen deficiency and hormone replacement a distraction to the field of osteoporosis?
    Kanis JA
    Osteoporos Int; 1998; 8 Suppl 1():S51-6. PubMed ID: 9682799
    [No Abstract]   [Full Text] [Related]  

  • 3. [Benefits and risks of postmenopausal hormone replacement therapy. Symptoms improved but not a better outcome?].
    MMW Fortschr Med; 2010 Jun; 152(24):18. PubMed ID: 20672580
    [No Abstract]   [Full Text] [Related]  

  • 4. Update on hormone replacement therapy.
    Gambrell RD
    Am Fam Physician; 1992 Nov; 46(5 Suppl):87S-96S. PubMed ID: 1442475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended hormone replacement: who should get it, and for how long?
    Langer RD; Barrett-Connor E
    Geriatrics; 1994 Dec; 49(12):20-4; 29. PubMed ID: 7982582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hormone therapy and menopause].
    Heutling D; Lehnert H
    Dtsch Med Wochenschr; 2005 Apr; 130(13):829-34. PubMed ID: 15789305
    [No Abstract]   [Full Text] [Related]  

  • 7. Postmenopausal hormone therapy and the risk of cardiovascular disease.
    Stramba-Badiale M
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):303-9. PubMed ID: 19430340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The menopausal transition: how does route of delivery affect the risk/benefit ratio of hormone therapy?
    Shulman LP
    J Fam Pract; 2004 Jul; Suppl():S13-7. PubMed ID: 15251108
    [No Abstract]   [Full Text] [Related]  

  • 9. Individualizing hormone-therapy according to cardiovascular risk.
    Shoupe D
    Minerva Ginecol; 2013 Dec; 65(6):631-9. PubMed ID: 24346251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Appropriate use of hormones should alleviate concerns of cardiovascular and breast cancer risk.
    Lobo RA
    Maturitas; 2005 May; 51(1):98-109. PubMed ID: 15883114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postmenopausal hormone replacement therapy and major clinical outcomes: a focus on cardiovascular disease, osteoporosis, dementia, and breast and endometrial neoplasia.
    Dick SE; DeWitt DE; Anawalt BD
    Am J Manag Care; 2002 Jan; 8(1):95-104; quiz 105-6. PubMed ID: 11814176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update: the latest on hormone replacement therapy.
    Packin GS
    J Am Osteopath Assoc; 2000 Oct; 100(10 Su Pt 1):S2-5. PubMed ID: 11105456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The menopause: benefits and risks of hormone replacement therapy.
    Gambrell RD
    Compr Ther; 1994; 20(10):580-5. PubMed ID: 7859441
    [No Abstract]   [Full Text] [Related]  

  • 14. Postmenopausal hormone therapy: from monkey glands to transdermal patches.
    Davis SR; Dinatale I; Rivera-Woll L; Davison S
    J Endocrinol; 2005 May; 185(2):207-22. PubMed ID: 15845914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hormone replacement therapy: curse or blessing?].
    Schmidt M; Fink D; Lang U; Kimmig R
    Gynakol Geburtshilfliche Rundsch; 2006; 46(4):165. PubMed ID: 17068400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Postmenopausal hormone-replacement therapy discredited, except in healthy women shortly after menopause].
    Maas AH; van der Graaf Y
    Ned Tijdschr Geneeskd; 2002 Nov; 146(45):2127-30. PubMed ID: 12474550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Menopause: refining benefits and risks of hormone replacement therapy.
    Cooper A; Whitehead M
    Curr Opin Obstet Gynecol; 1995 Jun; 7(3):214-9. PubMed ID: 7647275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there a case for targeting hormone replacement therapy for osteoporosis at the menopause?
    Stevenson JC
    Osteoporos Int; 1998; 8 Suppl 1():S47-50. PubMed ID: 9682798
    [No Abstract]   [Full Text] [Related]  

  • 19. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators.
    Nabulsi AA; Folsom AR; White A; Patsch W; Heiss G; Wu KK; Szklo M
    N Engl J Med; 1993 Apr; 328(15):1069-75. PubMed ID: 8384316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Historical perspective of hormone replacement therapy].
    Chanson P
    Rev Prat; 2005 Feb; 55(4):369-75. PubMed ID: 15828614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.